FibroGen, Inc. (FGEN) on Monday said that a Chinese regulator has approved the sale of its unit FibroGen International (Hong ...

While the numbers may seem high, they are still far below the pay of top executives in the United States, the study has found ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

FluMist has been approved since 2003, but—until last year—only for administration by a healthcare practitioner. The new nod ...

Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for ...

Coffee Day Enterprises reported a consolidated net profit of Rs 28 crore for Q1 FY26. This marks a sharp improvement from the ...

A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict ...

AstraZeneca, the U.K.-Swedish pharmaceutical giant, on Tuesday announced a plan to invest some $50 billion in the U.S. in a move hailed by the Trump administration — though much of what it is ...

He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating tactic to get a better deal from the British government, including on what ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for AstraZeneca’s ...

AstraZeneca Vietnam has been recognised as one of the “Best Companies to Work for in Asia 2025” by HR Asia, underscoring its ...